{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68813",
      "recalling_firm": "Wockhardt Usa Inc.",
      "address_1": "20 Waterview Blvd., Suite 3",
      "address_2": "N/A",
      "postal_code": "07054",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1513-2014",
      "product_description": "buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.",
      "product_quantity": "840 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.",
      "recall_initiation_date": "20140714",
      "center_classification_date": "20140805",
      "termination_date": "20150112",
      "report_date": "20140813",
      "code_info": "Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14"
    }
  ]
}